No new cardiovascular warnings needed for NSAIDs say FDA advisers
Posted on: 11/02/2014 - 23:00
SILVER SPRING, MD. – There do not need to be major changes to the warning labels on prescription and over-the-counter nonsteroidal anti-inflammatory medications, said a group of federal advisers on...
Field of Interest: Rheumatology
Type: News Item